---
schema_version: "secwatch.filing_event.v1"
accession: "0001396814-22-000070"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T19:47:17.671495+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pacira reports Oct 2022 preliminary net sales of $54.9M; EXPAREL average daily sales 106% of prior year

## Summary
- Preliminary unaudited net product sales of $54.9M for October 2022.
- EXPAREL net sales $45.0M (vs $42.5M Oct 2021); average daily sales 106% of prior year.
- ZILRETTA net sales $8.6M (acquired Nov 2021); iovera° net sales $1.3M (vs $1.2M).
- Company not providing FY2022 revenue/gross margin guidance due to COVID-19 uncertainty.
- CEO Dave Stack reiterates confidence in double-digit growth and value creation from partnerships.

## SEC filing metadata
- accession: 0001396814-22-000070
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000139681422000070/0001396814-22-000070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000139681422000070/pcrx-20221114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001396814-22-000070
- JSON: https://secwatch.observer/filing/0001396814-22-000070.json
- Plain text: https://secwatch.observer/filing/0001396814-22-000070.txt

## Key facts
- Earnings Releases
  Pacira BioSciences, Inc. reported month ended October 31, 2022 results: revenue $54.9 million.
  - Period: month ended October 31, 2022
  - Revenue: $54.9 million
  - Result: preliminary results
  source text: Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000139681422000070/0001396814-22-000070-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.